Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

News Conference News TVT 2023

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

Shelley Wood

June 14, 2023

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

News Conference News TVT 2023

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

Shelley Wood

June 08, 2023

Presentation TVT 2023

Analysis of Procedure Volume and Outcomes of Surgical and Transcatheter Aortic Valve Replacement Following Regulatory Approval of Low-Surgical Risk Patients

Presenter: Ghadi Moubarak

June 08, 2023

Presentation TVT 2023

Association of Low Geriatric Nutritional Risk Index With Transcatheter Aortic Valve Replacement Procedural Futility

Presenter: Rohit Masih

June 08, 2023

Presentation TVT 2023

Contrapoint: M-TEER in Lower Risk PMR Patients: Putting the “Pro” and “Cons” in Perspective

Presenter: Michael Mack

June 08, 2023

Presentation TVT 2023

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

Presenter: Amar Krishnaswamy

June 08, 2023

Presentation TVT 2023

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

Presenter: Firas Zahr

June 08, 2023

Advertisement

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

Analysis of Procedure Volume and Outcomes of Surgical and Transcatheter Aortic Valve Replacement Following Regulatory Approval of Low-Surgical Risk Patients

Association of Low Geriatric Nutritional Risk Index With Transcatheter Aortic Valve Replacement Procedural Futility

Contrapoint: M-TEER in Lower Risk PMR Patients: Putting the “Pro” and “Cons” in Perspective

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content